Related Experiment Video
Updated: Sep 18, 2025

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Overview of Cellular Therapeutics Clinical Trials: Advances, Challenges, and Future Directions
Meizhai Guo1, Bingyi Zheng1, Xiaoling Zeng1
1Translational Medicine Research Center, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China.
Abstract:
Cellular therapeutics, encompassing stem cell-based regeneration and engineered immune cell platforms, have demonstrated efficacy in treating degenerative diseases, immune-related diseases, and oncology. However, low engraftment rates and limited long-term efficacy remain critical translational barriers. This review compiled clinical projects on cell therapy in China over the past five years (over 1200 patients across 172 clinical trials) to highlight its rapid development in recent years and illustrate the directions of indications for application. This review also analyzes published clinical achievements all over the world, revealing significant therapeutic improvements in degenerative disorders (40-60% improvement in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores and oncology (78% ctDNA clearance, p < 0.001)). We propose integrating traditional Chinese medicine (TCM) bioactive compounds to enhance cell viability via C-X-C motif chemokine receptor (CXCR4) upregulation and mitochondrial biogenesis. Despite mechanistic insights, translational barriers include limited TCM validation (72% lacking single-cell omics) and regulatory misalignment. Future efforts should prioritize randomized trials and standardized TCM-cell therapy protocols to bridge discovery and clinical translation.
Insights
Cellular therapies show promise for degenerative diseases and cancer, but face challenges. Integrating traditional Chinese medicine (TCM) may improve cell viability and overcome these barriers for better clinical translation.
Area of Science:
- Regenerative Medicine
- Immunotherapy
- Oncology
Background:
- Cellular therapeutics, including stem cells and engineered immune cells, show efficacy but face low engraftment and limited long-term success.
- Translational barriers hinder the clinical application of cell therapies.
Purpose of the Study:
- To review clinical cell therapy projects in China over the past five years.
- To analyze global clinical achievements and identify therapeutic improvements.
- To propose integrating traditional Chinese medicine (TCM) to enhance cell therapy efficacy.
Main Methods:
- Compilation of clinical projects on cell therapy in China (172 trials, >1200 patients).
- Analysis of published global clinical achievements in cell therapy.
- Review of proposed mechanisms for TCM integration (CXCR4 upregulation, mitochondrial biogenesis).
Main Results:
- Significant therapeutic improvements observed in degenerative disorders (40-60% WOMAC score improvement) and oncology (78% ctDNA clearance).
- Rapid development and diverse applications of cell therapy highlighted.
- Identified limitations in TCM validation (72% lacking single-cell omics) and regulatory issues.
Conclusions:
- Cellular therapeutics offer significant therapeutic potential, particularly in degenerative diseases and oncology.
- Integrating TCM bioactive compounds presents a promising strategy to enhance cell viability and overcome translational barriers.
- Future research should focus on randomized trials and standardized TCM-cell therapy protocols to facilitate clinical translation.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview
Microorganisms in Medicine and Therapeutics
Drug Discovery: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

